A Malignant Transformation of a Spinal Epidural Mass from Ganglioneuroblastoma to Neuroblastoma

Mehmet Akçakaya, Bilge Bılgıç, Yavuz Aras, Nail İzgiJournal of Korean Neurosurgical Society 2015 · DOI

Abstract

Ganglioneuromas are benign tumors. Surgical excision is the treatment of choice with very good prognosis. However, neuroblastomatous malignant transformation of ganglioneuromas was previously reported. We report a patient with spinal neuroblastoma recurrent from a ganglioneuroblastoma after disease free survival of 13 years. This is one of the rare examples of spinal neuroblastoma and to our knowledge the second case report with malignant transformation from a ganglioneuroblastoma or a ganglioneuroma. The present case is the only report in the literature with further genetic investigations.

Introduction

Neuroblastic tumors represent a spectrum of neural crest-derived neoplasms, ranging from the benign, well-differentiated ganglioneuroma (GN) to the intermediate ganglioneuroblastoma (GNB), and finally to the highly malignant, undifferentiated neuroblastoma (NB). While the natural history of these tumors often involves "maturation"—a process where malignant cells differentiate into benign forms—the reverse process of "dedifferentiation" or malignant transformation is exceedingly rare.

This phenomenon is particularly unusual in adults, as neuroblastoma is primarily a pediatric malignancy, with nearly 90% of cases diagnosed before the age of 10. Consequently, adult spinal neuroblastomas lack standardized diagnostic and prognostic frameworks. This paper documents a rare case of a spinal mass transforming from a GNB into an aggressive NB over a 13-year period, providing the first detailed genetic analysis of such a transformation in an adult.

Case Presentation

The patient, a 22-year-old male, had a significant medical history involving a spinal tumor first diagnosed at age 9. At that time, he underwent a T10-11 laminectomy and tumor resection. The initial pathology was consistent with ganglioneuroblastoma. Following a period of 13 years of disease-free survival, the patient presented with a recurrence.

Clinical imaging revealed a new mass in the spinal epidural space. To address the recurrence and associated neurological risks, a third surgical intervention—a T10 hemilaminectomy—was performed to resect the tumor.

MRI of the recurrent T10 epidural mass.

Pathological and Genetic Analysis

Histopathological examination of the recurrent mass revealed a stark shift in tumor morphology. While the original tumor contained mature ganglion cells characteristic of GNB, the recurrent tumor was composed entirely of small, round, malignant blue cells, diagnostic of pure neuroblastoma. Immunohistochemistry (IHC) confirmed the neural origin of these cells, showing strong positivity for CD56 (a neural cell adhesion molecule) and synaptophysin.

Histological transformation to neuroblastoma: (A) H&E stain, (B) CD56 IHC, (C) Synaptophysin IHC.

A critical component of this study was the genetic analysis using Interphase Fluorescent In Situ Hybridisation (FISH). In pediatric neuroblastoma, amplification of the n-myc (2p24) gene and deletions of chromosomes 1p and 11q are hallmark indicators of poor prognosis and aggressive behavior. Surprisingly, despite the aggressive clinical transformation observed in this adult patient, FISH analysis was negative for all three markers.

Discussion

This case challenges the traditional clinical assumption that neuroblastic tumors move exclusively toward a benign state. The dedifferentiation observed here, occurring after more than a decade of dormancy, suggests that the "maturation" rule is not absolute.

A retrospective review of the patient's original biopsy revealed a microscopic (1.5 mm) cellular area of round blastic cells. This finding is significant, as it suggests that even tiny clusters of undifferentiated cells can remain quiescent for years before serving as the seed for malignant transformation.

The negative genetic results are perhaps the most intriguing finding. The absence of standard pediatric markers (n-myc, 1p, 11q) in a clearly malignant adult tumor implies that adult spinal neuroblastomas may be driven by oncogenic pathways distinct from those seen in children. This highlights a need for broader genetic profiling, such as whole-exome sequencing, in adult cases to identify the true drivers of dedifferentiation.

Furthermore, the patient's long-term survival (over 13 years) is notably better than the typical prognosis for adult neuroblastoma, which is often less than two years. This suggests that spinal or paraspinal variants of the disease might follow a more favorable clinical course than other presentations.

Conclusion

The malignant transformation of a spinal ganglioneuroblastoma into a neuroblastoma is a rare but clinically significant event. This case underscores the importance of long-term follow-up for patients with "benign" or intermediate neuroblastic tumors. While standard pediatric genetic markers failed to explain the malignancy in this instance, the case provides a vital data point for understanding adult neuroblastoma. Future research should focus on identifying the unique genetic signatures of adult dedifferentiation to improve diagnostic and therapeutic strategies.

Summary updated

Abstract

Ganglioneuromas are benign tumors. Surgical excision is the treatment of choice with very good prognosis. However, neuroblastomatous malignant transformation of ganglioneuromas was previously reported. We report a patient with spinal neuroblastoma recurrent from a ganglioneuroblastoma after disease free survival of 13 years. This is one of the rare examples of spinal neuroblastoma and to our knowledge the second case report with malignant transformation from a ganglioneuroblastoma or a ganglioneuroma. The present case is the only report in the literature with further genetic investigations.
BibTeX
@article{akcakaya2015malignant,
  author = {Mehmet Akçakaya and Bilge Bılgıç and Yavuz Aras and Nail İzgi},
  title = {{A Malignant Transformation of a Spinal Epidural Mass from Ganglioneuroblastoma to Neuroblastoma}},
  journal = {Journal of Korean Neurosurgical Society},
  year = {2015},
  doi = {10.3340/jkns.2015.57.3.211},
}
Figure